0.24 (-%)
As of Dec 15, 2023
Source:
We are a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the Central Nervous System, or CNS. Our company was founded on the premise that the upper nasal space can be an optimal treatment entry point for CNS and other diseases where rapid vascular absorption can result in superior clinical outcomes.
Country | United States |
Headquarters | seattle, washington |
Phone Number | 206-568-1466 |
Industry | manufacturing |
CEO | Adrian Adams |
Website |